Want to see BRTX full AI Analyst Report?
BioRestorative Therapies (BRTX) Stock Forecast & Price Target
BRTX Analyst Ratings
BRTX Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Michael Okunewitch | Maxim Group | ― | hold | ― | Downgraded | 10/06/26 | ||
| Jonathan Aschoff | Roth MKM | $18→$15 | buy | 893.38%Upside | Reiterated | 04/02/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Michael OkunewitchMaxim Group | HoldDowngraded | 10/06/26 | ― | ||
| Jonathan AschoffRoth MKM | BuyReiterated$18→$15 | 04/02/26 | 893.38%Upside |
Best Analysts Covering BioRestorative Therapies
Copying Jonathan Aschoff's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +5.38% per trade.
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -29.26% per trade.
Copying Jonathan Aschoff's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -80.12% per trade.
BRTX Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 0 | 0 | 0 | 1 |
In the current month, BRTX has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. BRTX average Analyst price target in the past 3 months is ―.
BRTX Financial Forecast
BRTX Sales Forecast
Next quarter’s sales forecast for BRTX is $0 with a range of ― to ―. The previous quarter’s sales results were $23.17K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
